Resolute Onyx™ DES
Resolute Onyx Drug Eluting Stent Receives FDA Approval for New 1 Month DAPT Labeling With Expanded Indication for HBR Patients Implanted with the Resolute...
Clinical studies have demonstrated that Resolute Onyx DES and its biocompatible polymer and stent design promote fast vessel healing and is well-suited for patients who may benefit from a DAPT duration as short as one month.
Medtronic Resolute Onyx DES Receives First and Only One-Month DAPT Indication for High Bleeding Risk Patients in Europe
Resolute Onyx DES is available for use in the United States, as well as in Europe and other countries that recognize the CE Mark. Resolute Onyx DES is not currently indicated for HBR patients with one-month DAPT in the United States. Data have been submitted to the FDA with the intent of obtaining a one-month DAPT US Indication for Resolute Onyx DES.
